Vivo Opportunity Fund Holdings, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Regulus Therapeutics Inc. Common Stock, $0.001 par value (RGLS)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Regulus Therapeutics Inc. Common Stock, $0.001 par value
Symbol
RGLS
Shares outstanding
69,139,128 shares
Disclosed Ownership
2,696,426 shares
Ownership
3.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 08:35:13 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 3.9% ownership in Regulus Therapeutics Inc. Common Stock, $0.001 par value (RGLS) on 31 Mar 2025."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G/A for Regulus Therapeutics Inc. Common Stock, $0.001 par value (RGLS).
  • Disclosed ownership: 3.9%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 08:35.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 3.9% 2,696,426 2,696,426 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity, LLC 3.9% 2,696,426 2,696,426 0 /s/ Kevin Dai Kevin Dai/Managing Member